33rd Annual Symposium on NHP Models for AIDS
第 33 届 NHP 艾滋病模型年度研讨会
基本信息
- 批准号:9065384
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAnimal ModelAnimalsAreaAwardBiotechnologyCaliforniaCollaborationsCytomegalovirusDestinationsDevelopmentDiseaseEducational workshopFamilyFeesFosteringFundingGenomicsHIVHIV InfectionsHIV therapyHIV vaccineHealthcare SystemsImmunologyIndividualIndustryInfectionInfection preventionInstitutionInternationalInvestigationJournalsKnowledgeManuscriptsMedicalModelingOralPathogenesisPatientsPharmacologic SubstancePreventionPrevention strategyPrimatesPublicationsRecording of previous eventsRecordsRequest for ApplicationsResearchResearch PersonnelReview CommitteeSan FranciscoScheduleScientistSelection CriteriaTimeTranslationsUnited States National Institutes of HealthUniversitiesViral Pathogenesisabstractingbaseclinical careclinical practicecongenital cytomegaloviruscostexperienceinnovationmeetingsmembermicrobiomenonhuman primatenovelnovel strategiesoriginalityposterspre-clinicalprogramsprotective efficacypublic health relevancesuccesssymposiumtherapeutic vaccinetransmission processvirology
项目摘要
DESCRIPTION (provided by applicant): This R13 application request funds to partially support the costs for planning, organizing, publicizing, and hosting the 33rd Annual Symposium on Nonhuman Primate Models for AIDS. The Symposium will be hosted by the California National Primate Research Center (CNPRC), University of California, Davis (UC Davis), and will be held on October 14-16, 2015, at the Portola Hotel, Monterey, California. The Annual Symposium on Nonhuman Primate Models for AIDS has become the destination for the sharing, presenting and exchanging the most recent advances in AIDS research utilizing nonhuman primate models of AIDS. An attendance of approximately 250 scientists from national and international academic institutions and private industry is expected based on the past records of the conference participation. The most recent findings in viral pathogenesis, immunology, virology, vaccines, therapeutics, and genomics will be presented. Novel approaches for HIV eradication strategies will be discussed. An emphasis of this year's symposium is to provide forums for dialog between clinicians and researchers to facilitate refinement of the animal models of HIV in ways that enhance translation of prevention, treatment, and cure findings in animals to HIV patients. The meeting will consist of a combination of platform presentations and poster sessions. The scientific sessions will be devoted to specific focus areas of research. Each session will be hosted by an invited Chair and a co-Chair. The Chair will moderate the first half of the session and will begin the session by giving a 30- minute overview presentation. The co-Chair will moderate the second half of the session and facilitate discussion at the end of each session. The Scientific Program Committee consists of 14 members representing the National Primate Centers, academic institutions, and pharmaceutical and biotechnology industry, and the committee will review abstracts and assign oral or poster presentation for each of the scientific sessions. The conference organizing committee (nine members) will participate in the planning and organization of the conference. Criteria for selection of the abstracts will be
based on the originality and quality of the content. Those individuals giving platform presentations will be asked to submit their presentations in manuscript form for publication in the Journal of Medical Primatology (Dr. Preston Marx, Tulane, will serve as Editor). In addition, there will be poster sessions for those meritorious presentations that cannot be accommodated in one of the five platform sessions. The conference will include an opening day welcome reception and introductory talk (Dr. Murray Gardner, UC Davis) followed by a keynote presentation by Dr. James Hildreth (UC Davis/Meharry University), recipient of the NIH Director's Pioneer Award. On the second day, platform presentations and a poster session reception will be held. On the third day of the symposium, a banquet will be hosted following the platform presentations and a poster session. The proposed conference will facilitate an exchange of most recent findings, new ideas and concepts and collaborative interactions to define the mechanisms of HIV disease and to develop multi-disciplinary collaborative interactions for innovative studies on HIV vaccines to prevent infection and therapies to control and eradicate HIV infection.
描述(由申请人提供):此 R13 申请请求资金来部分支持规划、组织、宣传和举办第 33 届非人类灵长类动物艾滋病模型年度研讨会的费用。该研讨会将由加州国家灵长类动物研究中心 (California National Primate Research Center) 主办。 CNPRC)、加州大学戴维斯分校 (UC Davis) 将于 2015 年 10 月 14 日至 16 日在加利福尼亚州蒙特雷波托拉酒店举行。非人灵长类艾滋病模型研讨会已成为分享、展示和交流利用非人灵长类艾滋病模型进行艾滋病研究最新进展的场所,预计将有来自国内外学术机构和私营企业的约 250 名科学家参加。会议重点将介绍病毒发病机制、免疫学、病毒学、疫苗、治疗学和基因组学方面的最新发现。今年的研讨会旨在为公众和研究人员之间的对话提供论坛,以促进艾滋病毒动物模型的完善,从而加强将动物的治疗、治疗和治愈预防结果转化为艾滋病毒患者。科学会议将专门讨论特定的重点研究领域。每场会议将由一位受邀主席和一位联合主席主持,并以发言开始会议。 30 分钟的概述演示。联合主席将主持会议的下半场,并在每场会议结束时促进讨论。科学计划委员会由代表国家灵长类动物中心、学术机构以及制药和生物技术行业的 14 名成员组成,委员会将审查摘要。会议组委会(九名成员)将参与会议的规划和组织摘要的选择标准。
根据内容的原创性和质量,那些进行平台演示的个人将被要求以手稿形式提交其演示文稿,以便在《医学灵长类动物学杂志》上发表(杜兰大学的普雷斯顿·马克思博士将担任编辑)。将为那些无法在五个平台会议之一中容纳的优秀演讲举办海报会议,会议将包括开幕日欢迎招待会和介绍性演讲(加州大学戴维斯分校的 Murray Gardner 博士),随后由 Dr. Murray Gardner 进行主题演讲。 James Hildreth(加州大学戴维斯分校/梅哈里大学),美国国立卫生研究院院长先锋奖获得者 第二天,将举行平台演讲和海报会议招待会。第三天,平台后将举办宴会。拟议的会议将促进最新发现、新想法和概念的交流以及协作互动,以定义艾滋病毒疾病的机制,并为艾滋病毒疫苗的感染预防和创新研究发展多学科协作互动。疗法控制和消除艾滋病毒感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Satya Dandekar其他文献
Satya Dandekar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Satya Dandekar', 18)}}的其他基金
Molecules and Pathways at the Coccidioides Host-Pathogen Interface
球孢子菌宿主-病原体界面的分子和途径
- 批准号:
10364963 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Immune and metabolic correlates of Coccidioides disease spectrum and outcomes
球孢子菌疾病谱和结果的免疫和代谢相关性
- 批准号:
10364969 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Molecules and Pathways at the Coccidioides Host-Pathogen Interface
球孢子菌宿主-病原体界面的分子和途径
- 批准号:
10540795 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Immune and metabolic correlates of Coccidioides disease spectrum and outcomes
球孢子菌疾病谱和结果的免疫和代谢相关性
- 批准号:
10540815 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10023879 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10368941 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10579905 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs
早期艾滋病毒对肠道免疫和炎症的影响,以播种病毒库
- 批准号:
9154447 - 财政年份:2016
- 资助金额:
$ 7.5万 - 项目类别:
INTESTINAL CYTOKINE AND T CELL HEMEOSTASIS IN SIV INFECTION
SIV 感染中的肠道细胞因子和 T 细胞止血作用
- 批准号:
8357367 - 财政年份:2011
- 资助金额:
$ 7.5万 - 项目类别:
PATHOGENESIS OF INTESTINAL DYSFUNCTION IN SIMIAN AIDS
猿猴艾滋病肠功能障碍的发病机制
- 批准号:
8357341 - 财政年份:2011
- 资助金额:
$ 7.5万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
- 批准号:
10389392 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
- 批准号:
10654524 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别: